BioSpace News Archive

Press Releases

Alnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial Results

July 17, 2025
·
1 min read
Press Releases

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

July 17, 2025
·
6 min read
Press Releases

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

July 17, 2025
·
8 min read
Press Releases

Cantargia Announces Preliminary Topline Efficacy Results From the Phase 2 TRIFOUR Trial of Nadunolimab in Advanced Triple-Negative Breast Cancer (TNBC)

July 17, 2025
·
6 min read
Press Releases

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

July 17, 2025
·
2 min read
Press Releases

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

July 17, 2025
·
1 min read
Press Releases

Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress

July 17, 2025
·
6 min read
Press Releases

Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas

July 17, 2025
·
7 min read
Press Releases

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer

July 17, 2025
·
8 min read
Press Releases

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease

July 17, 2025
·
7 min read